University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial NC-HEM-07-2

A Phase III, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of GAMMAPLEX in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Phase: Phase III
Status: Not Open (Closed)
Treatments: Immunotherapy
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Howard Liebman, M.D.
Other Trial Staff:  Brad Hutchinson, R.N., Melissa Peralta, D.M.

Staff may log in to see study documents.

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.